+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Treating Cushing's Disease in Dogs Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Treating Cushing's Disease in Dogs Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Treating Cushing's Disease in Dogs Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6079429
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Canine Cushing’s disease, also known as hyperadrenocorticism, represents a complex endocrine disorder that progressively impacts the quality of life in affected dogs. Characterized by an overproduction of cortisol, this condition manifests through a spectrum of clinical signs including polyuria, polydipsia, alopecia, muscle weakness, and increased susceptibility to infections. Veterinary practitioners and pet owners alike face significant challenges in achieving accurate diagnosis and effective long-term management due to the disease’s multifactorial nature. Advances in diagnostic methodologies, therapeutic modalities, and holistic support measures continue to redefine the standard of care, creating new opportunities for better outcomes. This executive summary synthesizes the most critical developments in disease staging, product innovation, regulatory influences, regional adoption patterns, and competitive positioning. The goal is to equip decision-makers with a concise yet comprehensive overview of current market dynamics and to highlight actionable trends shaping the future of Cushing’s disease treatment in dogs.

Transformative Shifts Reshaping Canine Cushing’s Disease Care

The landscape of canine Cushing’s disease care has undergone fundamental transformation driven by breakthroughs in surgical techniques and targeted therapies. Surgical interventions, once considered high-risk, now benefit from advances in minimally invasive procedures and improved perioperative care protocols. Concurrently, the rise of radiation therapy has expanded options for pituitary-dependent cases, offering non-surgical routes to mitigate tumor growth. On the pharmaceutical front, novel injectable and oral medications harness precise enzyme inhibition to regulate cortisol synthesis more effectively, reducing adverse effects and fostering better long-term control. Holistic support, encompassing herbal formulations, omega-3 fatty acids and antioxidant supplementation, has gained traction within integrative veterinary teams. Moreover, monitoring technologies and telemedicine platforms have accelerated early detection and personalized treatment adjustments, enabling continuous feedback loops between clinicians and pet owners. Taken together, these transformative shifts underscore the dynamic co-evolution of medical science, digital innovation and client engagement, laying the groundwork for more resilient therapeutic strategies.

Assessing the 2025 U.S. Tariff Impacts on Treatment Accessibility

In 2025, updated tariff structures in the United States have introduced new complexities to the importation and distribution of veterinary pharmaceuticals and medical devices. Elevated duties on certain hormone assays and injectable drug components have raised the cost base for hydrocortisone injections and vetoryl (trilostane) injections, prompting some distributors to negotiate alternative sourcing or to absorb marginal increases. Concurrently, tariffs on specialized diagnostic kits-such as those used for ACTH stimulation and dexamethasone suppression tests-have marginally inflated procedure costs in reference laboratories. These incremental cost pressures risk dampening access to early-stage monitoring for dog owners and may drive veterinarians to selectively prioritize in-office diagnostics over more comprehensive third-party testing. However, some manufacturers have offset these effects by localizing production of key supplies or redesigning formulations to qualify for preferential tariff classifications. As a consequence, market participants who proactively adapt supply chains and total cost of care models will be better positioned to maintain affordability while sustaining diagnostic accuracy and therapeutic efficacy.

Key Insights from Market Segmentation Analysis

A detailed segmentation analysis reveals contrasting adoption patterns and growth prospects across multiple axes. Examining product type, advanced therapies-comprising radiation therapy and surgical interventions-tend to dominate treatment strategies in tertiary care centers, while dietary supplements and natural remedies such as herbal formulations, omega-3 fatty acids and vitamins and antioxidants have achieved strong penetration among pet owners pursuing adjunctive or preventive regimens. Injectable medications, notably hydrocortisone injections and vetoryl injections, find favor for acute management and inpatient settings, whereas oral medications-including ketoconazole tablets, mitotane tablets and trilostane capsules-are preferred for chronic outpatient dosing. When segmented by disease stage, early-stage Cushing’s disease emphasizes routine monitoring, moderate-stage cases often leverage combination therapies to balance efficacy and tolerance, and late-stage presentations demand intensive care regimens that integrate supportive nutrition and critical care protocols. Diagnosis method segmentation highlights the prevalence of ACTH stimulation testing and dexamethasone suppression testing, further differentiated into high-dose and low-dose protocols, alongside the non-invasive urine cortisol creatinine ratio test that is gaining traction in primary clinics. Treatment setting analysis contrasts home-based care and specialty animal hospitals with veterinary clinics, including general practices, where client education and telemonitoring enable decentralized management. Insights by dog size indicate that large breeds such as Golden Retrievers and Labrador Retrievers exhibit higher incidence rates, medium breeds like Bulldogs and Cocker Spaniels often require tailored dose adjustments, and small breeds including Pomeranians and Yorkshire Terriers pose challenges in precise formulation. Finally, age group segmentation underscores that adult dogs form the majority of cases, senior dogs-especially heritage breeds-frequently experience comorbidities requiring integrated geriatric care, and young dogs, although less common, benefit from early intervention strategies.

Regional Dynamics Driving Therapeutic Adoption

Regional dynamics exert a significant influence on treatment access, regulatory pathways and therapeutic preferences. In the Americas, robust veterinary care infrastructure and a high prevalence of pet insurance support widespread adoption of advanced diagnostics and therapies, yet rising import duties require strategic procurement adjustments. Across Europe, Middle East & Africa, centralized regulatory frameworks and a mature specialty hospital network facilitate the adoption of surgical and radiation modalities, while growing interest in natural supplements is reshaping companion animal wellness initiatives. Meanwhile, the Asia-Pacific region demonstrates rapid growth driven by expanding pet ownership, increasing disposable incomes and government initiatives to standardize veterinary care; local manufacturers are partnering with global innovators to introduce cost-effective oral formulations and telehealth platforms that address vast geographic needs. Understanding these regional nuances is critical for tailoring distribution strategies, aligning regulatory submissions, and cultivating partnerships that accelerate technology transfer and localized service models.

Competitive Landscape and Leading Industry Players

The competitive landscape is defined by a mix of multinational pharmaceutical leaders, specialized veterinarians and emerging biotech innovators. Key players include Bayer Animal Health now part of Elanco, Boehringer Ingelheim Animal Health USA Inc., Ceva Santé Animale and Dechra Pharmaceuticals PLC, each leveraging global distribution networks and extensive R&D pipelines. Elanco Animal Health Inc. and Merck Animal Health maintain broad portfolios spanning injectable and oral treatments, while Norbrook Laboratories Limited and Virbac focus on formulation innovation for niche segments. Zoetis Inc. continues to lead in diagnostic assay development, complemented by IDEXX Laboratories, Inc.'s laboratory services and analyzers. Nutritional therapies are spearheaded by Hill’s Pet Nutrition, Inc. and Royal Canin as divisions of Mars Petcare, with VetriScience Laboratories and Vetoquinol USA Inc. delivering an array of adjunctive supplement solutions. Collaboration, licensing agreements and strategic acquisitions remain prevalent as companies seek to expand indication labels, improve bioavailability and streamline supply chains to mitigate tariff impacts. Understanding each organization’s differentiators, from clinical trial design to distribution channel expertise, enables stakeholders to benchmark performance and identify partnership or investment opportunities.

Actionable Strategies for Industry Leadership

To capitalize on evolving market dynamics and technological innovations, industry leaders should prioritize several strategic initiatives. First, integrating advanced diagnostics and telemonitoring into bundled care offerings can enhance early detection and treatment adherence, particularly in underserved regions. Second, diversifying product portfolios across both pharmacological and nutraceutical segments will address the full spectrum of disease stages and client preferences while mitigating regulatory or tariff exposure. Third, investing in localized manufacturing or strategic partnerships within key regions-especially in the Asia-Pacific and Europe, Middle East & Africa-can reduce lead times and adapt formulations to regional breed profiles and age demographics. Fourth, expanding educational programs for veterinarians and pet owners that emphasize combination therapies and best practices for monitoring will reinforce brand leadership and patient loyalty. Finally, maintaining agile supply-chain management and scenario-planning capabilities will ensure resilience against future regulatory changes or global disruptions, safeguarding consistent access to critical therapies.

Conclusion: Charting the Future of Canine Cushing’s Care

In summary, the treatment of canine Cushing’s disease is at an inflection point where multidisciplinary care, technological integration and strategic market adaptations converge to redefine best practices. Stakeholders who align their portfolios with nuanced segmentation insights, navigate regional complexities with targeted approaches, and forge partnerships that bridge innovation and local execution will lead the next wave of growth. By embracing a proactive stance on tariff mitigation, supply-chain resilience and stakeholder education, the industry can deliver superior health outcomes and capture value across diverse geographies and client segments.

Market Segmentation & Coverage

This research report categorizes the Treating Cushing's Disease in Dogs Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Advanced Therapies
    • Radiation Therapy
    • Surgical Interventions
  • Dietary Supplements and Natural Remedies
    • Herbal Formulations
    • Omega-3 Fatty Acids
    • Vitamins and Antioxidants
  • Injectable Medications
    • Hydrocortisone Injections
    • Vetoryl (Trilostane) Injections
  • Oral Medications
    • Ketoconazole Tablets
    • Mitotane Tablets
    • Trilostane Capsules
  • Early-Stage Cushing's Disease
    • Monitoring
  • Late-Stage Cushing's Disease
    • Intensive Care Regimens
  • Moderate-Stage Cushing's Disease
    • Combination Therapies
  • ACTH Stimulations Test
  • Dexamethasone Suppression Test
    • High-Dose Test
    • Low-Dose Test
  • Urine Cortisol Creatinine Ratio Test
  • Home-Based Care
  • Specialty Animal Hospitals
  • Veterinary Clinics
    • General Veterinary Practices
  • Large Breeds
    • Golden Retrievers
    • Labrador Retrievers
  • Medium Breeds
    • Bulldogs
    • Cocker Spaniels
  • Small Breeds
    • Pomeranians
    • Yorkshire Terriers
  • Adult Dogs
  • Senior Dogs
    • Heritage Breeds
  • Young Dogs

This research report categorizes the Treating Cushing's Disease in Dogs Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Treating Cushing's Disease in Dogs Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Bayer Animal Health (now part of Elanco)
  • Boehringer Ingelheim Animal Health USA Inc.
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc.
  • Hill’s Pet Nutrition, Inc.
  • IDEXX Laboratories, Inc.
  • Merck Animal Health (a division of Merck & Co., Inc.)
  • Norbrook Laboratories Limited
  • Royal Canin (a division of Mars Petcare)
  • Vetoquinol USA Inc.
  • VetriScience Laboratories
  • Virbac
  • Zoetis Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Treating Cushing's Disease in Dogs Market, by Product Type
8.1. Introduction
8.2. Advanced Therapies
8.2.1. Radiation Therapy
8.2.2. Surgical Interventions
8.3. Dietary Supplements and Natural Remedies
8.3.1. Herbal Formulations
8.3.2. Omega-3 Fatty Acids
8.3.3. Vitamins and Antioxidants
8.4. Injectable Medications
8.4.1. Hydrocortisone Injections
8.4.2. Vetoryl (Trilostane) Injections
8.5. Oral Medications
8.5.1. Ketoconazole Tablets
8.5.2. Mitotane Tablets
8.5.3. Trilostane Capsules
9. Treating Cushing's Disease in Dogs Market, by By Disease Stage
9.1. Introduction
9.2. Early-Stage Cushing's Disease
9.2.1. Monitoring
9.3. Late-Stage Cushing's Disease
9.3.1. Intensive Care Regimens
9.4. Moderate-Stage Cushing's Disease
9.4.1. Combination Therapies
10. Treating Cushing's Disease in Dogs Market, by By Diagnosis Method
10.1. Introduction
10.2. ACTH Stimulations Test
10.3. Dexamethasone Suppression Test
10.3.1. High-Dose Test
10.3.2. Low-Dose Test
10.4. Urine Cortisol Creatinine Ratio Test
11. Treating Cushing's Disease in Dogs Market, by By Treatment Setting
11.1. Introduction
11.2. Home-Based Care
11.3. Specialty Animal Hospitals
11.4. Veterinary Clinics
11.4.1. General Veterinary Practices
12. Treating Cushing's Disease in Dogs Market, by By Dog Size
12.1. Introduction
12.2. Large Breeds
12.2.1. Golden Retrievers
12.2.2. Labrador Retrievers
12.3. Medium Breeds
12.3.1. Bulldogs
12.3.2. Cocker Spaniels
12.4. Small Breeds
12.4.1. Pomeranians
12.4.2. Yorkshire Terriers
13. Treating Cushing's Disease in Dogs Market, by By Age Group
13.1. Introduction
13.2. Adult Dogs
13.3. Senior Dogs
13.3.1. Heritage Breeds
13.4. Young Dogs
14. Americas Treating Cushing's Disease in Dogs Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Treating Cushing's Disease in Dogs Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Treating Cushing's Disease in Dogs Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Bayer Animal Health (now part of Elanco)
17.3.2. Boehringer Ingelheim Animal Health USA Inc.
17.3.3. Ceva Santé Animale
17.3.4. Dechra Pharmaceuticals PLC
17.3.5. Elanco Animal Health Inc.
17.3.6. Hill’s Pet Nutrition, Inc.
17.3.7. IDEXX Laboratories, Inc.
17.3.8. Merck Animal Health (a division of Merck & Co., Inc.)
17.3.9. Norbrook Laboratories Limited
17.3.10. Royal Canin (a division of Mars Petcare)
17.3.11. Vetoquinol USA Inc.
17.3.12. VetriScience Laboratories
17.3.13. Virbac
17.3.14. Zoetis Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. TREATING CUSHING'S DISEASE IN DOGS MARKET MULTI-CURRENCY
FIGURE 2. TREATING CUSHING'S DISEASE IN DOGS MARKET MULTI-LANGUAGE
FIGURE 3. TREATING CUSHING'S DISEASE IN DOGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. TREATING CUSHING'S DISEASE IN DOGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. TREATING CUSHING'S DISEASE IN DOGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TREATING CUSHING'S DISEASE IN DOGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SURGICAL INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL REMEDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY HERBAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY OMEGA-3 FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VITAMINS AND ANTIOXIDANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INJECTABLE MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY HYDROCORTISONE INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETORYL (TRILOSTANE) INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INJECTABLE MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY KETOCONAZOLE TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MITOTANE TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY TRILOSTANE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY EARLY-STAGE CUSHING'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY EARLY-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LATE-STAGE CUSHING'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INTENSIVE CARE REGIMENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MODERATE-STAGE CUSHING'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY COMBINATION THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MODERATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ACTH STIMULATIONS TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY HIGH-DOSE TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LOW-DOSE TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY URINE CORTISOL CREATININE RATIO TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY HOME-BASED CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SPECIALTY ANIMAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY GENERAL VETERINARY PRACTICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LARGE BREEDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY GOLDEN RETRIEVERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LABRADOR RETRIEVERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LARGE BREEDS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MEDIUM BREEDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BULLDOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY COCKER SPANIELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MEDIUM BREEDS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SMALL BREEDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY POMERANIANS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY YORKSHIRE TERRIERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SMALL BREEDS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADULT DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SENIOR DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY HERITAGE BREEDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SENIOR DOGS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY YOUNG DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INJECTABLE MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY EARLY-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MODERATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LARGE BREEDS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MEDIUM BREEDS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SMALL BREEDS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SENIOR DOGS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INJECTABLE MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY EARLY-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MODERATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LARGE BREEDS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MEDIUM BREEDS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SMALL BREEDS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SENIOR DOGS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INJECTABLE MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY EARLY-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MODERATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LARGE BREEDS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MEDIUM BREEDS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SMALL BREEDS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SENIOR DOGS, 2018-2030 (USD MILLION)
TABLE 125. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, 2018-2030 (USD MILLION)
TABLE 127. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 128. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INJECTABLE MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 129. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 130. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 131. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY EARLY-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 132. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 133. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MODERATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 134. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 135. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, 2018-2030 (USD MILLION)
TABLE 136. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 137. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 138. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 139. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LARGE BREEDS, 2018-2030 (USD MILLION)
TABLE 140. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MEDIUM BREEDS, 2018-2030 (USD MILLION)
TABLE 141. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SMALL BREEDS, 2018-2030 (USD MILLION)
TABLE 142. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 143. CANADA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SENIOR DOGS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, 2018-2030 (USD MILLION)
TABLE 146. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 147. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INJECTABLE MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 148. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 150. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY EARLY-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 151. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 152. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MODERATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 153. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 154. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, 2018-2030 (USD MILLION)
TABLE 155. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 156. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 157. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 158. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LARGE BREEDS, 2018-2030 (USD MILLION)
TABLE 159. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MEDIUM BREEDS, 2018-2030 (USD MILLION)
TABLE 160. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SMALL BREEDS, 2018-2030 (USD MILLION)
TABLE 161. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 162. MEXICO TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SENIOR DOGS, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INJECTABLE MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY EARLY-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MODERATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LARGE BREEDS, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MEDIUM BREEDS, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SMALL BREEDS, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SENIOR DOGS, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INJECTABLE MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY EARLY-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MODERATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LARGE BREEDS, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MEDIUM BREEDS, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SMALL BREEDS, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SENIOR DOGS, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, 2018-2030 (USD MILLION)
TABLE 205. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INJECTABLE MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY EARLY-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MODERATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LARGE BREEDS, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MEDIUM BREEDS, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SMALL BREEDS, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SENIOR DOGS, 2018-2030 (USD MILLION)
TABLE 222. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, 2018-2030 (USD MILLION)
TABLE 224. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 225. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INJECTABLE MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 226. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 227. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 228. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY EARLY-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 229. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 230. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MODERATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 231. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 232. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, 2018-2030 (USD MILLION)
TABLE 233. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 234. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 235. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 236. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LARGE BREEDS, 2018-2030 (USD MILLION)
TABLE 237. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MEDIUM BREEDS, 2018-2030 (USD MILLION)
TABLE 238. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SMALL BREEDS, 2018-2030 (USD MILLION)
TABLE 239. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 240. CHINA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SENIOR DOGS, 2018-2030 (USD MILLION)
TABLE 241. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, 2018-2030 (USD MILLION)
TABLE 243. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 244. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INJECTABLE MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 245. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 246. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 247. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY EARLY-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 248. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 249. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MODERATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 250. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 251. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, 2018-2030 (USD MILLION)
TABLE 252. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 253. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 254. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 255. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LARGE BREEDS, 2018-2030 (USD MILLION)
TABLE 256. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MEDIUM BREEDS, 2018-2030 (USD MILLION)
TABLE 257. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SMALL BREEDS, 2018-2030 (USD MILLION)
TABLE 258. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 259. INDIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SENIOR DOGS, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL REMEDIES, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY INJECTABLE MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY EARLY-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 268. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MODERATE-STAGE CUSHING'S DISEASE, 2018-2030 (USD MILLION)
TABLE 269. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DIAGNOSIS METHOD, 2018-2030 (USD MILLION)
TABLE 270. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, 2018-2030 (USD MILLION)
TABLE 271. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY TREATMENT SETTING, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY LARGE BREEDS, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY MEDIUM BREEDS, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SMALL BREEDS, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY SENIOR DOGS, 2018-2030 (USD MILLION)
TABLE 279. JAPAN TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. JAPAN TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY ADVANCED THERAPIES, 2018-2030 (USD MILLION)
TABLE 281. JAPAN TREATING CUSHING'S DISEASE IN DOGS MARKET SIZE, BY DIETARY SUPPLEMENTS AND NATURAL RE

Companies Mentioned

  • Bayer Animal Health (now part of Elanco)
  • Boehringer Ingelheim Animal Health USA Inc.
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc.
  • Hill’s Pet Nutrition, Inc.
  • IDEXX Laboratories, Inc.
  • Merck Animal Health (a division of Merck & Co., Inc.)
  • Norbrook Laboratories Limited
  • Royal Canin (a division of Mars Petcare)
  • Vetoquinol USA Inc.
  • VetriScience Laboratories
  • Virbac
  • Zoetis Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Diabetes Mellitus in Cats and Dogs, An Issue of Veterinary Clinics of North America: Small Animal Practice. The Clinics: Veterinary Medicine Volume 53-3 - Product Image

Diabetes Mellitus in Cats and Dogs, An Issue of Veterinary Clinics of North America: Small Animal Practice. The Clinics: Veterinary Medicine Volume 53-3

  • Book
  • North America
Veterinary Endocrinology - Global Strategic Business Report - Product Image

Veterinary Endocrinology - Global Strategic Business Report

  • Report
  • 69 Pages
  • Global
From
United States Veterinary Eye Care Market, By Region, Competition, Forecast & Opportunities, 2019-2029F - Product Image

United States Veterinary Eye Care Market, By Region, Competition, Forecast & Opportunities, 2019-2029F

  • Report
  • 80 Pages
  • United States
From
North America Companion Animals Diagnostics Market, By Country, Competition, Opportunities and Forecast, 2019-2029F - Product Image

North America Companion Animals Diagnostics Market, By Country, Competition, Opportunities and Forecast, 2019-2029F

  • Report
  • 130 Pages
  • North America
From
U.S. Veterinary 3D Printing Market Size, Share & Trends Analysis Report by Animal Type (Dogs, Cats), Application (Therapeutic, Others), Material, Products, End-use, and Segment Forecasts, 2024-2030 - Product Image

U.S. Veterinary 3D Printing Market Size, Share & Trends Analysis Report by Animal Type (Dogs, Cats), Application (Therapeutic, Others), Material, Products, End-use, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.